In California, a Decision on Cannabis Delivery Remains up in the Air
Last year, 24 cities and one county challenged the state’s top cannabis regulator for approving cannabis delivery in jurisdictions that banned cannabis businesses.
Latest Stories
Ag regulators to USDA: extend hemp pilot program • Texas’ ban on smokable hemp challenged • & more…
By Cannabis Wire Editors Newsletter
Q&A: California State Treasurer Fiona Ma Talks Cannabis, Safe Banking, and Social Equity
By Sophie Putka Business, California
FDA Approves Epidiolex for New Condition That Causes Benign Tumors, Seizures
Epidiolex contains cannabidiol, or CBD, extracted from cannabis plants, and was first approved to treat severe forms of epilepsy.
House Passes Spending Bill with Cannabis Protections
The protections range from expanding banking access to preventing federal interference in states with legal cannabis, but passage in the Senate is uncertain.
Colorado: New State Work Group Holds First Meeting on Cannabis Equity
Two meetings this summer will focus on recently-passed legislation that aims to expand equity in the cannabis industry.
Saint Lucia Joins the Race to Legalize Cannabis
The nation’s leaders have agreed to draw up adult-use legislation and set a date to vote on it.
Hemp Groups to Meet with White House on FDA CBD Policy
The Food and Drug Administration drafted its long-awaited CBD policy, and sent it to the White House Office of Management and Budget for approval, a final step before publication.
Democrats’ 2020 platform excludes cannabis legalization • FDA wraps CBD policy draft • & more…
An excerpt from recent editions of the Cannabis Wire Daily newsletter.
Canopy Growth’s US Lobbying Footprint Expands
One of the world’s largest cannabis companies is now lobbying in at least a half dozen states.
Today, Texas’ Cannabis Industry Is Tiny. Cannabis Giants See Potential.
Cannabis Wire has found that major cannabis companies, like Canopy Growth, are registered to lobby.
Who Is Now Lobbying on Cannabis, CBD, and Hemp?
Altria and Anheuser-Busch, previously lobbying on hemp and cannabis respectively, have now specified CBD as an area of interest.
